Cerebrospinal fluid M staging for medulloblastoma: Reappraisal of Chang's M staging based on the CSF flow

Neuro-Oncology

Volumn 13, Issue 3, 2011, Pages 334-344

  Phi, Ji Hoon ^a   Lee, Joongyub ^b   Wang, Kyu Chang ^a   Cho, Byung Kyu ^a   Kim, In One ^c   Park, Chul Kee ^c   Kim, Chae Yong ^e   Ahn, Hyo Seop ^a,f   Kim, Il Han ^d,f   Kim, Seung Ki ^a  

^a Seoul National University Children's Hospital   (South Korea)

^b Medical Research Collaborating Center   (South Korea)

^c Department of Diagnostic Radiology ^*  (South Korea)

^d Seoul National University Hospital   (South Korea)

^e Seoul National University Bundang Hospital   (South Korea)

^f Seoul National University College of Medicine   (South Korea)

Author keywords

Cerebrospinal fluid; Medulloblastoma; Prognosis; Seeding; Staging

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; LOMUSTINE; METHOTREXATE; VINCRISTINE;

ADOLESCENT; ADULT; ARTICLE; BRAIN TUMOR; CANCER STAGING; CANCER SURVIVAL; CEREBELLUM TUMOR; CEREBROSPINAL FLUID FLOW; CEREBROSPINAL FLUID M STAGING; CHILD; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; INFANT; MAJOR CLINICAL STUDY; MALE; MEDULLOBLASTOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PREOPERATIVE EVALUATION; PRESCHOOL CHILD; PROGNOSIS; PROGRESSION FREE SURVIVAL; SCHOOL CHILD; SUBARACHNOID SPACE; TREATMENT OUTCOME; TUMOR SEEDING;

ADOLESCENT; ADULT; CEREBELLAR NEOPLASMS; CEREBROSPINAL FLUID; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; MAGNETIC RESONANCE IMAGING; MALE; MEDULLOBLASTOMA; NEOPLASM STAGING; PROGNOSIS; YOUNG ADULT;

EID: 79955754391     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1093/neuonc/noq171     Document Type: Article

References (25)

1. Chang CH, Housepian EM, Herbert C, Jr. An operative staging system and a megavoltage radiotherapeutic technic for cerebellar medulloblastomas. Radiology. 1969;93(6):1351-1359.
2. Evans AE, Jenkin RD, Sposto R, et al. The treatment of medulloblastoma. Results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine, and prednisone. J Neurosurg. 1990;72(4):572-582. (Pubitemid 20113683)
3. Krischer JP, Ragab AH, Kun L, et al. Nitrogen mustard, vincristine, procarbazine, and prednisone as adjuvant chemotherapy in the treatment of medulloblastoma. A Pediatric Oncology Group study. J Neurosurg. 1991;74(6):905-909.
4. Packer RJ, Goldwein J, Nicholson HS, et al. Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: A Children's Cancer Group Study. J Clin Oncol. 1999;17(7):2127-2136. (Pubitemid 29318845)
5. Rutkowski S, Bode U, Deinlein F, et al. Treatment of early childhood medulloblastoma by postoperative chemotherapy alone. N Engl J Med. 2005;352(10):978-986. (Pubitemid 40349500)
6. Fisher PG, Burger PC, Eberhart CG. Biologic risk stratification of medulloblastoma: the real time is now. J Clin Oncol. 2004;22(6):971-974. (Pubitemid 41095025)
7. Brandes AA, Paris MK. Review of the prognostic factors in medulloblastoma of children and adults. Crit Rev Oncol Hematol. 2004;50(2):121-128. (Pubitemid 38638739)
8. Jenkin D, Shabanah MA, Shail EA, et al. Prognostic factors for medulloblastoma. Int J Radiat Oncol Biol Phys. 2000;47(3):573-584. (Pubitemid 30317473)
9. Yao MS, Mehta MP, Boyett JM, et al. The effect of M-stage on patterns of failure in posterior fossa primitive neuroectodermal tumors treated on CCG-921: A phase III study in a high-risk patient population. Int J Radiat Oncol Biol Phys. 1997;38(3):469-476. (Pubitemid 27305005)
10. Harisiadis L, Chang CH. Medulloblastoma in children: A correlation between staging and results of treatment. Int J Radiat Oncol Biol Phys. 1977;2(9-10):833-841. (Pubitemid 8253089)
11. Zeltzer PM, Boyett JM, Finlay JL, et al. Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: Conclusions from the Children's Cancer Group 921 randomized phase III study. J Clin Oncol. 1999;17(3):832-845. (Pubitemid 29109313)
12. Sanders RP, Onar A, Boyett JM, et al. M1 Medulloblastoma: High risk at any age. J Neurooncol. 2008;90(3):351-355.
13. Taylor RE, Bailey CC, Robinson K, et al. Results of a randomized study of preradiation chemotherapy versus radiotherapy alone for nonmetastatic medulloblastoma: The International Society of Paediatric Oncology/ United Kingdom Children's Cancer Study Group PNET-3 Study. J Clin Oncol. 2003;21(8):1581-1591. (Pubitemid 46594113)
14. Rekate HL. The definition and classification of hydrocephalus: A personal recommendation to stimulate debate. Cerebrospinal Fluid Res. 2008;5:2.
15. Packer RJ, Cogen P, Vezina G, Rorke LB. Medulloblastoma: Clinical and biologic aspects. Neuro Oncol. 1999;1(3):232-250.
16. Allen J, Donahue B, Mehta M, et al. A phase II study of preradiotherapy chemotherapy followed by hyperfractionated radiotherapy for newly diagnosed high-risk medulloblastoma/primitive neuroectodermal tumor: A report from the Children's Oncology Group (CCG 9931). Int J Radiat Oncol Biol Phys. 2009;74(4): 1006-1011.
17. Geyer JR, Sposto R, Jennings M, et al. Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: A report from the Children's Cancer Group. J Clin Oncol. 2005;23(30): 7621-7631. (Pubitemid 46291826)
18. Fouladi M, Hunt DL, Pollack IF, et al. Outcome of children with centrally reviewed low-grade gliomas treated with chemotherapy with or without radiotherapy on Children's Cancer Group high-grade glioma study CCG-945. Cancer. 2003;98(6):1243-1252. (Pubitemid 37099910)
19. Detterbeck FC, Tanoue LT, Boffa DJ. Anatomy, biology and concepts, pertaining to lung cancer stage classification. J Thorac Oncol. 2009;4(4):437-443.
20. Gajjar A, Fouladi M, Walter AW, et al. Comparison of lumbar and shunt cerebrospinal fluid specimens for cytologic detection of leptomeningeal disease in pediatric patients with brain tumors. J Clin Oncol. 1999;17(6):1825-1828. (Pubitemid 29269253)
21. Chiro GD, Hammock MK, Bleyer WA. Spinal descent of cerebrospinal fluid in man. Neurology. 1976;26(1):1-8.
22. Greitz D, Hannerz J. A proposed model of cerebrospinal fluid circulation: observations with radionuclide cisternography. AJNR Am J Neuroradiol. 1996;17(3):431-438. (Pubitemid 26101944)
23. Eberhart CG, Kepner JL, Goldthwaite PT, et al. Histopathologic grading of medulloblastomas: A Pediatric Oncology Group study. Cancer. 2002;94(2):552-560. (Pubitemid 34081387)
24. Giangaspero F, Rigobello L, Badiali M, et al. Large-cell medulloblastomas. A distinct variant with highly aggressive behavior. Am J Surg Pathol. 1992;16(7):687-693.
25. Gajjar A, Hernan R, Kocak M, et al. Clinical, histopathologic, and molecular markers of prognosis: toward a new disease risk stratification system for medulloblastoma. J Clin Oncol. 2004;22(6):984-993. (Pubitemid 41095029)